Proficio Capital Partners’s Immunic IMUX Stock Holding History

Proficio Capital Partners’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-53	Closed	-$4K	–	2008
2019 Q1	$4K	Buy	+53	New	+$4.66K	﹤0.01%	1170

Other funds holding IMUX

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Proficio Capital Partners's IMUX Position: Q2 2019 in Review

Proficio Capital Partners sold out of Immunic (IMUX) in Q2 2019, closing a stake of 53 shares — an estimated $4K sold.

Proficio Capital Partners first reported a position in IMUX in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 24 funds tracked by Wall St. Rank hold IMUX as of Q2 2019.

Proficio Capital Partners reported no remaining Immunic position as of Q2 2019 after selling out during the quarter.
Proficio Capital Partners sold 53 Immunic shares in Q2 2019, an estimated $4K.
Proficio Capital Partners first reported a position in Immunic in Q1 2019 and held it in 1 quarter.
Proficio Capital Partners's Immunic position peaked at $4K in Q1 2019.
24 funds tracked by Wall St. Rank held Immunic as of Q2 2019.

Based on Proficio Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.